28 results
8-K
EX-10.3
CELU
Celularity Inc - Ordinary Shares
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified Person of a release
8-K
EX-10.3
CELU
Celularity Inc - Ordinary Shares
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.
4.1.4 The indemnification provided for under
8-K
EX-10.3
CELU
Celularity Inc - Ordinary Shares
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.
4.1.4 The indemnification provided for under
425
EX-10.1
CELU
Celularity Inc - Ordinary Shares
8 Jan 21
Business combination disclosure
7:02am
or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.
(iv) The indemnification provided
8-K
EX-10.1
1mdjv2j7xtv45
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
8-K
EX-10.3
235xn3
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
8-K
EX-10.1
u6mpf1om2ezzu89jw
15 Sep 22
Entry into a Material Definitive Agreement
4:11pm
8-K
EX-10.1
th48foy4o
15 Mar 24
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-1.1
9sqv7q
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-1.1
un6pvc
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
S-4/A
EX-10.23
1nax9 6xj9a
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
424B3
wiikw
1 Jun 22
Prospectus supplement
4:06pm
424B3
z1eil7vk
3 May 22
Prospectus supplement
4:06pm